Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.730
-0.040 (-1.44%)
At close: May 13, 2026, 4:00 PM EDT
2.730
0.00 (0.00%)
After-hours: May 13, 2026, 6:41 PM EDT
Cronos Group Revenue
Cronos Group had revenue of $45.21M in the quarter ending March 31, 2026, with 40.13% growth. This brings the company's revenue in the last twelve months to $159.54M, up 28.05% year-over-year. In the year 2025, Cronos Group had annual revenue of $146.59M with 24.63% growth.
Revenue (ttm)
$159.54M
Revenue Growth
+28.05%
P/S Ratio
6.44
Revenue / Employee
$261,533
Employees
610
Market Cap
1.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 146.59M | 28.97M | 24.63% |
| Dec 31, 2024 | 117.62M | 30.37M | 34.82% |
| Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
| Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
| Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
| Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
| Dec 31, 2019 | 23.75M | 11.63M | 95.94% |
| Dec 31, 2018 | 12.12M | 8.97M | 285.16% |
| Dec 31, 2017 | 3.15M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | -572.29K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Phibro Animal Health | 1.50B |
| Evotec SE | 859.03M |
| Collegium Pharmaceutical | 796.33M |
| Pacira BioSciences | 734.86M |
| Amphastar Pharmaceuticals | 720.53M |
| Alvotech | 562.04M |
| Esperion Therapeutics | 418.24M |
| Xeris Biopharma Holdings | 314.85M |
CRON News
- 1 day ago - Cronos Group price target raised to C$5.50 from C$4.50 at TD Securities - TheFly
- 1 day ago - Cronos Group Inc (CRON) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth ... - GuruFocus
- 1 day ago - Q1 2026 Cronos Group Inc Earnings Call Transcript - GuruFocus
- 1 day ago - Cronos Group Inc. (CRON) Reports Record Revenue and Market Growth in Q1 2026 - GuruFocus
- 2 days ago - Cronos Group (CRON) Q1 2026: EPS $0.04 Beats ($0.01 est), Revenue $45.2M Tops ($44. ... - GuruFocus
- 2 days ago - Cronos Group reports Q1 EPS 4c vs. 2c last year - TheFly
- 2 days ago - Cronos Group (CRON) Reports Strong Earnings and Strategic Expansion Plans - GuruFocus
- 2 days ago - Cronos Group (CRON) Reports Strong Q1 Earnings, Beats Expectations - GuruFocus